CHERYL BOURGAULT: Open Payments
NPI 1205823036 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 20 payments from 7 companies in 2025. Trend: 2023 $855 · 2024 $810 · 2025 $596
Food & beverage: $412Education: $184
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 4 | $210 |
| Janssen Biotech, Inc. | 7 | $159 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $109 |
| ABBVIE INC. | 3 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Galderma Laboratories, L.P. | 1 | $18 |
| Amgen Inc. | 1 | $14 |
Products named: Bimzelx, TREMFYA, RINVOQ, ILUMYA, LIBTAYO, NEMLUVIO, SKYRIZI, DUPIXENT.
Industry payments across OR — which companies pay providers there.
